ArticleEvidence-based complementary and alternative medicine : eCAM2022

Fuzi-Lizhong Decoction Alleviates Nonalcoholic Fatty Liver Disease by Blocking TLR4/MyD88/TRAF6 Signaling.

Jiayao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.